Allogeneic hematopoietic stem cell transplantation (HSCT) is one of curative treatment
options for patients with hematologic malignancies. Although GVHD mediated by the donor's …

NK cells are innate lymphocytes with protective functions against viral infections and tumor
formation. Human NK cells carry inhibitory killer cell Ig-like receptors (KIRs), which …

Delayed hematopoietic recovery and increased rate of engraftment failure limit the use of
umbilical cord blood transplantation (UCBT). We describe a case of severe aplastic anemia …

Chimerism testing supports the study of engraftment and measurable residual disease
(MRD) in patients after allogeneic hematopoietic stem cell transplant. In chimerism MRD …

Abstract aUCBT is a valuable curative option in pediatric patients with refractory idiopathic
SAA and no available matched sibling or unrelated donors. Experience in the use of …

Umbilical cord blood transplantation (UCBT) has increased access to potentially curative
therapy for patients with life-threatening disorders of the bone marrow and immune system …

The diversification of potential donors to perform stem cell allografts now enables to propose
a compatible graft cell source adapted to the different clinical situations. Transplants with a …

It has been established that hematopoietic chimerism after double umbilical cord blood
transplantation (dUCBT) can predict disease relapse and detect potential engraftment …

Coexisting hematopoiesis from donor and recipient origin, called a mixed chimerism status,
can occur in patients after myeloablative allogeneic hematopoietic stem cell transplantation …

T‐cell prolymphocytic leukemia (T‐PLL) is a rare and aggressive postthymic T‐cell
neoplasm with an associated survival time of 1 year when left untreated. Current standard of …